Treatment satisfaction in type 2 diabetes patients taking empagliflozin compared with patients taking glimepiride-Reference-Cited by-同舟云学术

Treatment satisfaction in type 2 diabetes patients taking empagliflozin compared with patients taking glimepiride

Published:2015-09-30 Issue:5 Volume:25 Page:1199-1207
ISSN:0962-9343
Container-title:Quality of Life Research
language:en
Short-container-title:Qual Life Res

Author:

Chirila Costel,Zheng Qingyao,Davenport Eric,Kaschinski Dagmar,Pfarr Egon,Hach Thomas,Palencia Roberto

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1007/s11136-015-1140-2.pdf

Reference19 articles.

1. International Diabetes Federation. (2013). IDF diabetes atlas (6th ed.). http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf . Accessed 26 Nov 2014.

2. Pyerot, M., & Rubin, R. R. (2009). How does treatment satisfaction work? Modeling determinants of treatment satisfaction and care. Diabetes Care, 32, 1411–1417.

3. Bradley, C., & Gamsu, D. S. (1994). Guidelines for encouraging psychological well-being: Report of a working group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabetic Medicine, 11, 510–516.

4. Bradley, C., & Gilbride, C. J. B. (2008). Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: The role of once-daily insulin glargine. Diabetes, Obesity and Metabolism Journal, 10(suppl 2), 50–65.

5. Blonde, L. (2010). Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus. The American Journal of Medicine, 123, S12–S18.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of SGLT‐2 Inhibitors With Treatment Satisfaction and Diabetes‐Specific and General Health Status in Adults With Cardiovascular Disease and Type 2 Diabetes;Journal of the American Heart Association;2023-09-05

2. Sodium-Glucose Co-Transporter 2 Inhibitors Use Improves the Satisfaction With Anti-diabetic Agent Treatment: A Questionnaire-based Propensity Score-matched Study;Frontiers in Pharmacology;2022-02-01

3. Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2019-04-18

4. Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study);Diabetology & Metabolic Syndrome;2018-03-01

5. Efficacy and safety of empagliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials;Postgraduate Medicine;2016-11-25